Pricing
Login
Home
Charts
Search
Watchlist
Products

Syngene International Ltd

SYNGENE
₹451.70+3.28%20 Nov 2026
Reports
Pharma CRAMS

Syngene International Ltd

SYNGENE
₹451.70
+3.28%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹18,234Cr
Close
Close Price
₹451.70
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
97.56
PS
Price To Sales
5.18
Revenue
Revenue
₹3,522Cr
Rev Gr TTM
Revenue Growth TTM
-5.99%
PAT Gr TTM
PAT Growth TTM
-60.25%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8549177908919441,0188759119171,037736833
Growth YoY
Revenue Growth YoY%
8.6-7.8-2.3-2.110.611.010.72.2-2.81.8-15.8-8.6
Expenses
ExpensesCr
622600620646660674668711708733645685
Operating Profit
Operating ProfitCr
23231717024528434420620020930391147
OPM
OPM%
27.134.621.527.530.133.823.621.922.829.312.317.7
Other Income
Other IncomeCr
2616501718191815-55161221
Interest Expense
Interest ExpenseCr
111312131216121312121010
Depreciation
DepreciationCr
108111107111109106111117114112112112
PBT
PBTCr
1382091011371812411018528196-1947
Tax
TaxCr
27202631505715181348-1015
PAT
PATCr
11218976106131183876715148-932
Growth YoY
PAT Growth YoY%
1.65.5-18.9-8.917.6-2.814.5-36.8-88.6-19.3-110.4-52.0
NPM
NPM%
13.120.69.611.913.918.09.97.41.614.3-1.23.9
EPS
EPS₹
2.84.71.92.63.34.62.21.70.43.7-0.20.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
8549177908919441,0188759119171,037736833
Growth YoY
Revenue Growth YoY%
8.6-7.8-2.3-2.110.611.010.72.2-2.81.8-15.8-8.6
Expenses
ExpensesCr
622600620646660674668711708733645685
Operating Profit
Operating ProfitCr
23231717024528434420620020930391147
OPM
OPM%
27.134.621.527.530.133.823.621.922.829.312.317.7
Other Income
Other IncomeCr
2616501718191815-55161221
Interest Expense
Interest ExpenseCr
111312131216121312121010
Depreciation
DepreciationCr
108111107111109106111117114112112112
PBT
PBTCr
1382091011371812411018528196-1947
Tax
TaxCr
27202631505715181348-1015
PAT
PATCr
11218976106131183876715148-932
Growth YoY
PAT Growth YoY%
1.65.5-18.9-8.917.6-2.814.5-36.8-88.6-19.3-110.4-52.0
NPM
NPM%
13.120.69.611.913.918.09.97.41.614.3-1.23.9
EPS
EPS₹
2.84.71.92.63.34.62.21.70.43.7-0.20.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,4231,8262,0122,1842,6043,1933,4893,6423,7393,522
Growth
Revenue Growth%
28.310.28.619.222.69.34.42.6-6.0
Expenses
ExpensesCr
9581,2891,3941,5131,8632,2592,4742,6012,8202,772
Operating Profit
Operating ProfitCr
4655376186727419341,0141,042919751
OPM
OPM%
32.729.430.730.828.529.329.128.624.621.3
Other Income
Other IncomeCr
6275153100777180104-6-6
Interest Expense
Interest ExpenseCr
23323528244547534944
Depreciation
DepreciationCr
131164219275310367426433453449
PBT
PBTCr
373415517469484594621660411252
Tax
TaxCr
678410564891291111649466
PAT
PATCr
305332412405396464510496317186
Growth
PAT Growth%
8.624.3-1.8-2.317.39.8-2.7-36.2-60.3
NPM
NPM%
21.518.220.518.515.214.514.613.68.55.3
EPS
EPS₹
7.74.210.410.29.911.612.712.37.94.6
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,4231,8262,0122,1842,6043,1933,4893,6423,7393,522
Growth
Revenue Growth%
28.310.28.619.222.69.34.42.6-6.0
Expenses
ExpensesCr
9581,2891,3941,5131,8632,2592,4742,6012,8202,772
Operating Profit
Operating ProfitCr
4655376186727419341,0141,042919751
OPM
OPM%
32.729.430.730.828.529.329.128.624.621.3
Other Income
Other IncomeCr
6275153100777180104-6-6
Interest Expense
Interest ExpenseCr
23323528244547534944
Depreciation
DepreciationCr
131164219275310367426433453449
PBT
PBTCr
373415517469484594621660411252
Tax
TaxCr
678410564891291111649466
PAT
PATCr
305332412405396464510496317186
Growth
PAT Growth%
8.624.3-1.8-2.317.39.8-2.7-36.2-60.3
NPM
NPM%
21.518.220.518.515.214.514.613.68.55.3
EPS
EPS₹
7.74.210.410.29.911.612.712.37.94.6
Sales CAGR
1 Year3%
3 Years5%
5 Years11%
TTM-6%
EBITDA CAGR
1 Year-12%
3 Years-1%
5 Years6%
TTM-27%
PAT CAGR
1 Year-36%
3 Years-12%
5 Years-5%
TTM-60%
Avg. ROCE
1 Year9%
3 Years12%
5 Years12%
TTM6%
CFO / EBITDA
1 Year100%
3 Years105%
5 Years97%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
200200400400401401402403403404
Reserves
ReservesCr
1,5201,7681,7762,4212,8973,2173,8564,3244,4364,455
Current Liabilities
Current LiabilitiesCr
7841,1291,5391,1331,2291,1881,1441,3961,5521,183
Non Current Liabilities
Non Current LiabilitiesCr
6856074489291,0371,025750673663617
Total Liabilities
Total LiabilitiesCr
3,1893,7044,1634,8835,5645,8316,1526,7967,0556,659
Current Assets
Current AssetsCr
1,7201,7641,6131,8072,2062,4251,9592,2872,1431,948
Non Current Assets
Non Current AssetsCr
1,4691,9392,5503,0773,3583,4064,1934,5094,9124,710
Total Assets
Total AssetsCr
3,1893,7044,1634,8835,5645,8316,1526,7967,0556,659
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
200200400400401401402403403404
Reserves
ReservesCr
1,5201,7681,7762,4212,8973,2173,8564,3244,4364,455
Current Liabilities
Current LiabilitiesCr
7841,1291,5391,1331,2291,1881,1441,3961,5521,183
Non Current Liabilities
Non Current LiabilitiesCr
6856074489291,0371,025750673663617
Total Liabilities
Total LiabilitiesCr
3,1893,7044,1634,8835,5645,8316,1526,7967,0556,659
Current Assets
Current AssetsCr
1,7201,7641,6131,8072,2062,4251,9592,2872,1431,948
Non Current Assets
Non Current AssetsCr
1,4691,9392,5503,0773,3583,4064,1934,5094,9124,710
Total Assets
Total AssetsCr
3,1893,7044,1634,8835,5645,8316,1526,7967,0556,659

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4466306777015818241,0421,168915
Investing Cash Flow
Investing Cash FlowCr
-349-647-428-628-612-656-496-745-860
Financing Cash Flow
Financing Cash FlowCr
-79-72-22658-31-343-551-142-215
Net Cash Flow
Net Cash FlowCr
18-8923131-62-175-5281-160
Free Cash Flow
Free Cash FlowCr
904947260105317572407571
CFO To PAT
CFO To PAT%
146.1190.1164.3173.2146.7177.3204.3235.3289.0
CFO To EBITDA
CFO To EBITDA%
96.0117.4109.6104.478.388.1102.7112.199.6
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4466306777015818241,0421,168915
Investing Cash Flow
Investing Cash FlowCr
-349-647-428-628-612-656-496-745-860
Financing Cash Flow
Financing Cash FlowCr
-79-72-22658-31-343-551-142-215
Net Cash Flow
Net Cash FlowCr
18-8923131-62-175-5281-160
Free Cash Flow
Free Cash FlowCr
904947260105317572407571
CFO To PAT
CFO To PAT%
146.1190.1164.3173.2146.7177.3204.3235.3289.0
CFO To EBITDA
CFO To EBITDA%
96.0117.4109.6104.478.388.1102.7112.199.6

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,77611,7599,66221,73423,92423,86728,20929,22815,72518,234
Price To Earnings
Price To Earnings
38.635.523.453.760.451.455.358.949.697.6
Price To Sales
Price To Sales
8.36.44.89.99.27.58.18.04.25.2
Price To Book
Price To Book
6.86.04.47.77.36.66.66.23.33.8
EV To EBITDA
EV To EBITDA
24.722.115.832.733.025.927.827.916.724.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
65.063.366.266.862.664.464.364.365.265.2
OPM
OPM%
32.729.430.730.828.529.329.128.624.621.3
NPM
NPM%
21.518.220.518.515.214.514.613.68.55.3
ROCE
ROCE%
16.617.821.413.411.814.413.913.48.76.0
ROE
ROE%
17.816.918.914.312.012.812.010.56.53.8
ROA
ROA%
9.68.99.98.37.18.08.37.34.52.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
11,77611,7599,66221,73423,92423,86728,20929,22815,72518,234
Price To Earnings
Price To Earnings
38.635.523.453.760.451.455.358.949.697.6
Price To Sales
Price To Sales
8.36.44.89.99.27.58.18.04.25.2
Price To Book
Price To Book
6.86.04.47.77.36.66.66.23.33.8
EV To EBITDA
EV To EBITDA
24.722.115.832.733.025.927.827.916.724.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
65.063.366.266.862.664.464.364.365.265.2
OPM
OPM%
32.729.430.730.828.529.329.128.624.621.3
NPM
NPM%
21.518.220.518.515.214.514.613.68.55.3
ROCE
ROCE%
16.617.821.413.411.814.413.913.48.76.0
ROE
ROE%
17.816.918.914.312.012.812.010.56.53.8
ROA
ROA%
9.68.99.98.37.18.08.37.34.52.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr31,38526,48318,45518,2349,7975,5952,722
Close PriceClose₹3,833.5020,642.001,609.30451.70517.60977.80220.76
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE71.4758.5297.5632.3533.56
Price To SalesPS19.7111.4810.965.188.943.001.47
RevenueRevenueCr1,5932,3071,6843,5221,0961,8651,851
Revenue Growth TTMRev Gr TTM%45.2%50.5%10.7%-6.0%-7.0%36.8%8.9%
PAT Growth TTMPAT Gr TTM%95.8%88.4%-104.1%-60.3%-19.0%34.0%-149.5%
Market CapitalizationMkt CapCr31,38526,48318,45518,2349,7975,5952,722
Close PriceClose₹3,833.5020,642.001,609.30451.70517.60977.80220.76
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE71.4758.5297.5632.3533.56
Price To SalesPS19.7111.4810.965.188.943.001.47
RevenueRevenueCr1,5932,3071,6843,5221,0961,8651,851
Revenue Growth TTMRev Gr TTM%45.2%50.5%10.7%-6.0%-7.0%36.8%8.9%
PAT Growth TTMPAT Gr TTM%95.8%88.4%-104.1%-60.3%-19.0%34.0%-149.5%
Interviews